Search tips
Search criteria 


Logo of jrsocmedLink to Publisher's site
J R Soc Med. 1985 October; 78(10): 844–848.
PMCID: PMC1289951

New properties and roles for eosinophils in disease: discussion paper.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (782K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Basran GS, Page CP, Paul W, Morley J. Platelet-activating factor: a possible mediator of the dual response to allergen? Clin Allergy. 1984 Jan;14(1):75–79. [PubMed]
  • Bass DA, Grover WH, Lewis JC, DeChatelet LR, McCall CE. Stimulation or activation of eosinophils in vivo during eosinophilia: possible role of arachidonic acid metabolism. Adv Exp Med Biol. 1982;141:509–518. [PubMed]
  • Basten A, Beeson PB. Mechanism of eosinophilia. II. Role of the lymphocyte. J Exp Med. 1970 Jun 1;131(6):1288–1305. [PMC free article] [PubMed]
  • Beeson PB, Bass DA. The eosinophil. Major Probl Intern Med. 1977;14:1–269. [PubMed]
  • Davies J, Spry CJ, Sapsford R, Olsen EG, de Perez G, Oakley CM, Goodwin JF. Cardiovascular features of 11 patients with eosinophilic endomyocardial disease. Q J Med. 1983 Winter;52(205):23–39. [PubMed]
  • Dessein AJ, Vadas MA, Nicola NA, Metcalf D, David JR. Enhancement of human blood eosinophil cytotoxicity by semi-purified eosinophil colony-stimulating factor(s). J Exp Med. 1982 Jul 1;156(1):90–103. [PMC free article] [PubMed]
  • Flaum MA, Schooley RT, Fauci AS, Gralnick HR. A clinicopathologic correlation of the idiopathic hypereosinophilic syndrome. I. Hematologic manifestations. Blood. 1981 Nov;58(5):1012–1020. [PubMed]
  • Gleich GJ, Loegering DA. Immunobiology of eosinophils. Annu Rev Immunol. 1984;2:429–459. [PubMed]
  • Gleich GJ, Loegering DA, Adolphson CR. Eosinophils and bronchial inflammation. Chest. 1985 Jan;87(1 Suppl):10S–13S. [PubMed]
  • Hällgren R, Venge P, Cullhed I, Olsson I. Blood eosinophils and eosinophil cationic protein after acute myocardial infarction or corticosteroid administration. Br J Haematol. 1979 May;42(1):147–154. [PubMed]
  • Henderson WR, Harley JB, Fauci AS. Arachidonic acid metabolism in normal and hypereosinophilic syndrome human eosinophils: generation of leukotrienes B4, C4, D4 and 15-lipoxygenase products. Immunology. 1984 Apr;51(4):679–686. [PubMed]
  • Khalife J, Capron M, Grzych JM, Bazin H, Capron A. Extracellular release of rat eosinophil peroxidase (EPO) I. Role of anaphylactic immunoglobulins. J Immunol. 1985 Mar;134(3):1968–1974. [PubMed]
  • Lee T, Lenihan DJ, Malone B, Roddy LL, Wasserman SI. Increased biosynthesis of platelet-activating factor in activated human eosinophils. J Biol Chem. 1984 May 10;259(9):5526–5530. [PubMed]
  • López AF, Vadas MA. Stimulation of human granulocyte function by monoclonal antibody WEM-G1. Proc Natl Acad Sci U S A. 1984 Mar;81(6):1818–1821. [PubMed]
  • Lotze MT, Robb RJ, Sharrow SO, Frana LW, Rosenberg SA. Systemic administration of interleukin-2 in humans. J Biol Response Mod. 1984 Oct;3(5):475–482. [PubMed]
  • Moore PM, Harley JB, Fauci AS. Neurologic dysfunction in the idiopathic hypereosinophilic syndrome. Ann Intern Med. 1985 Jan;102(1):109–114. [PubMed]
  • Olsen EG, Spry CJ. Relation between eosinophilia and endomyocardial disease. Prog Cardiovasc Dis. 1985 Jan-Feb;27(4):241–254. [PubMed]
  • Prin L, Capron M, Tonnel AB, Bletry O, Capron A. Heterogeneity of human peripheral blood eosinophils: variability in cell density and cytotoxic ability in relation to the level and the origin of hypereosinophilia. Int Arch Allergy Appl Immunol. 1983;72(4):336–346. [PubMed]
  • Schooley RT, Flaum MA, Gralnick HR, Fauci AS. A clinicopathologic correlation of the idiopathic hypereosinophilic syndrome. II. Clinical manifestations. Blood. 1981 Nov;58(5):1021–1026. [PubMed]
  • Slungaard A, Ascensao J, Zanjani E, Jacob HS. Pulmonary carcinoma with eosinophilia. Demonstration of a tumor-derived eosinophilopoietic factor. N Engl J Med. 1983 Sep 29;309(13):778–781. [PubMed]
  • Spry CJ. The hypereosinophilic syndrome: clinical features, laboratory findings and treatment. Allergy. 1982 Nov;37(8):539–551. [PubMed]
  • Spry CJ, Davies J, Tai PC, Olsen EG, Oakley CM, Goodwin JF. Clinical features of fifteen patients with the hypereosinophilic syndrome. Q J Med. 1983 Winter;52(205):1–22. [PubMed]
  • Spry CJ, Tai PC. Studies on blood eosinophils. II. Patients with Löffler's cardiomyopathy. Clin Exp Immunol. 1976 Jun;24(3):423–434. [PubMed]
  • Spry CJ, Tai PC, Barkans J. Tissue localization of human eosinophil cationic proteins in allergic diseases. Int Arch Allergy Appl Immunol. 1985;77(1-2):252–254. [PubMed]
  • Sun XH, Davis WB, Fukuda Y, Ferrans VJ, Crystal RG. Experimental polymyxin B-induced interstitial lung disease characterized by an accumulation of cytotoxic eosinophils in the alveolar structures. Am Rev Respir Dis. 1985 Jan;131(1):103–108. [PubMed]
  • Tai PC, Bakes DM, Barkans JR, Spry CJ. Plasma membrane antigens on light density and activated human blood eosinophils. Clin Exp Immunol. 1985 May;60(2):427–436. [PubMed]
  • Tai PC, Hayes DJ, Clark JB, Spry CJ. Toxic effects of human eosinophil products on isolated rat heart cells in vitro. Biochem J. 1982 Apr 15;204(1):75–80. [PubMed]
  • Tai PC, Holt ME, Denny P, Gibbs AR, Williams BD, Spry CJ. Deposition of eosinophil cationic protein in granulomas in allergic granulomatosis and vasculitis: the Churg-Strauss syndrome. Br Med J (Clin Res Ed) 1984 Aug 18;289(6442):400–402. [PMC free article] [PubMed]
  • Tai PC, Spry CJ. Enzymes altering the binding capacity of human blood eosinophils for IgG antibody-coated erythrocytes (EA). Clin Exp Immunol. 1980 Apr;40(1):206–219. [PubMed]
  • Tai PC, Spry CJ, Peterson C, Venge P, Olsson I. Monoclonal antibodies distinguish between storage and secreted forms of eosinophil cationic protein. Nature. 1984 May 10;309(5964):182–184. [PubMed]
  • Vadas MA. Cyclophosphamide pretreatment induces eosinophilia to nonparasite antigens. J Immunol. 1981 Nov;127(5):2083–2086. [PubMed]
  • Vadas MA. Genetic control of eosinophilia in mice: gene(s) expressed in bone marrow-derived cells control high responsiveness. J Immunol. 1982 Feb;128(2):691–695. [PubMed]
  • Vadas MA, Nicola N, Lopez AF, Metcalf D, Johnson G, Pereira A. Mononuclear cell-mediated enhancement of granulocyte function in man. J Immunol. 1984 Jul;133(1):202–207. [PubMed]
  • Veith M, Taylor DW, Thorne K, Richardson BA, Butterworth AE. Studies on the enhancement of human eosinophil function by mononuclear cell products in vitro. Clin Exp Immunol. 1984 Dec;58(3):603–610. [PubMed]
  • Warren DJ, Sanderson CJ. Production of a T-cell hybrid producing a lymphokine stimulating eosinophil differentiation. Immunology. 1985 Apr;54(4):615–623. [PubMed]
  • Weller PF, Bach DS, Austen KF. Biochemical characterization of human eosinophil Charcot-Leyden crystal protein (lysophospholipase). J Biol Chem. 1984 Dec 25;259(24):15100–15105. [PubMed]

Articles from Journal of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press